Page 143 - 南京医科大学自然版
P. 143
第44卷第5期 陈锦泉,丁紫藤,唐立钧,等. 乳腺专用PET在乳腺癌中的临床应用进展[J].
2024年5月 南京医科大学学报(自然科学版),2024,44(5):726-731 ·731 ·
[31]李翠翠,杨 琦,王荣福,等. 乳腺癌的分子核医学研究 ous FAPI PET/MRI targeting the fibroblast⁃activation pro⁃
进展[J]. 中国肿瘤临床,2022,49(4):193-196 tein for breast cancer[J]. Radiology,2022,302(1):39-47
[32]JONES E F,RAY K M,LI W,et al. Initial experience of [34]PABST K M,DECKER T,KERSTING D,et al. The future
dedicated breast PET imaging of ER+ breast cancers us⁃ role of PET imaging in metastatic breast cancer[J]. Oncol
ing[F⁃18]fluoroestradiol[J]. Npj Breast Cancer,2019,5: Res Treat,2022,45(1⁃2):18-25
12 [收稿日期] 2024-01-30
[33]BACKHAUS P,BURG M C,ROLL W,et al. Simultane⁃ (本文编辑:唐 震)
(上接第704页) ization,and inflammatory cytokine release[J]. Brain Sci,
[74]FILIPELLO F,GOLDSBURY C,YOU S F,et al. Soluble 2023,13(4):642
TREM2:innocent bystander or active player in neurologi⁃ [81]QIAO W H,CHEN Y X,ZHONG J,et al. Trem2 H157Y
cal diseases?[J]. Neurobiol Dis,2022,165:105630 increases soluble TREM2 production and reduces amy⁃
[75]DONG M H,ZHOU L Q,TANG Y,et al. CSF sTREM2 in loid pathology[J]. Mol Neurodegener,2023,18(1):8
neurological diseases:a two⁃sample Mendelian randomiza⁃ [82]SONG C H,SHI J Y,ZHANG P G,et al. Immunotherapy
tion study[J]. J Neuroinflammation,2022,19(1):79 for Alzheimer’s disease:targeting β ⁃ amyloid and be⁃
[76]HOU J C,CHEN Y,GRAJALES⁃REYES G,et al. TREM2 yond[J]. Transl Neurodegener,2022,11(1):18
dependent and independent functions of microglia in [83]SCHLEPCKOW K,MORENAS⁃RODRÍGUEZ E,HONG
Alzheimer’s disease[J]. Mol Neurodegener,2022,17 S,et al. Stimulation of TREM2 with agonistic antibodies⁃an
(1):84 emerging therapeutic option for Alzheimer’s disease[J].
[77]COSKER K,MALLACH A,LIMAYE J,et al. Microglial Lancet Neurol,2023,22(11):1048-1060
signalling pathway deficits associated with the patient de⁃ [84]WANG S T,MUSTAFA M,YUEDE C M,et al. Anti⁃hu⁃
rived R47H TREM2 variants linked to AD indicate inabil⁃ man TREM2 induces microglia proliferation and reduces
ity to activate inflammasome[J]. Sci Rep,2021,11(1): pathology in an Alzheimer’s disease model[J]. J Exp
13316 Med,2020,217(9):e20200785
[78]POPESCU A S,BUTLER C A,ALLENDORF D H,et al. [85] VIGIL NEUROSCIENCE. Vigil neuroscience announces
Alzheimer’s disease⁃associated R47H TREM2 increases, first participant dosed in phase 1 clinical trial in healthy
but wild⁃type TREM2 decreases,microglial phagocytosis volunteers evaluating VG ⁃ 3927,a small molecule
of synaptosomes and neuronal loss[J]. Glia,2023,71(4): TREM2 agonist,for potential treatment of Alzheimer’s
974-990 disease[EB/OL].(2023⁃10⁃17)[2024⁃01⁃15]. https://
[79]WU Z H,YANG S Y,FANG X M,et al. Function and investors.vigilneuro.com/news⁃releases/news⁃release⁃de⁃
mechanism of TREM2 in bacterial infection[J]. PLoS Pat⁃ tails/vigil⁃neuroscience⁃announces⁃first⁃participant⁃dosed
hog,2024,20(1):e1011895 ⁃phase⁃1.
[80]FU X X,CHEN S Y,LIAN H W,et al. The TREM2 [收稿日期] 2024-01-25
H157Y variant influences microglial phagocytosis,polar⁃ (本文编辑:陈汐敏)